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1090Objective: Outcomes data for adults undergoing congenital heart surgery are limited. Previous analyses used
administrative data or focused on single-center outcomes. We describe the most common operations, patient
characteristics, and postoperative outcomes using a multicenter clinical database.
Methods: The study included adults (aged  18 years) listed in the Society of Thoracic Surgeons Congenital
Heart Surgery Database (2000–2009). We describe patient characteristics and morbidity and mortality, and ex-
amine congenital procedures in the Society of Thoracic Surgeons Adult Cardiac Surgery Database to permit con-
sideration of the primary dataset within a broader context.
Results: A total of 5265 patients (68 centers) from the Society of Thoracic Surgeons Congenital Heart Surgery
Database were included. Patients’ median age was 25 years (interquartile range, 20–35). Common preoperative
risk factors included noncardiac abnormalities (17%) and arrhythmia (14%). Overall, in-hospital mortality was
2.1%, 27% had 1 or more complication, and median length of stay was 5 days. Common operations included
right ventricular outflow tract procedures (21%) and pacemaker/arrhythmia procedures (20%). We further eval-
uated cardiopulmonary bypass procedures in more than 100 patients. Mortality ranged from 0% (atrial septal
defect repair) to 11% (Fontan revision/conversion). Separate evaluation of the Society of Thoracic Surgeons
Adult Cardiac Surgery Database revealed 39,872 adults undergoing congenital heart operations.
Conclusions:Most adult congenital heart operations listed in the Society of Thoracic Surgeons Congenital Heart
Surgery Database are performed in the third to fourth decades of life; approximately half are for right heart
pathology or arrhythmia. Many patients have complications, but mortality is low with the exception of those
undergoing Fontan revision/conversion. Many more adults undergoing congenital heart surgery are entered
into the Society of Thoracic Surgeons Adult Cardiac Surgery Database. (J Thorac Cardiovasc Surg
2011;142:1090-7)Recent estimates of the US population of adults with con-
genital heart disease (CHD) range from 1 to 3 million.1
Only recently have these estimates exceeded those of pedi-
atric patients with congenital heart disease.2-4 There are
many reasons for emergence of this population. As
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The Journal of Thoracic and Cardiovascular Surmost complex operations has dramatically improved over
the past 2 decades.5 Advancements in supportive disci-
plines, including intensive care, have coincided with these
operative improvements.2,6 Although most infants and
children who undergo operations for congenital heart
disease survive, the surgery rarely offers a definitive cure.
With the exception of atrial septal defect (ASD) repair,
the life expectancy of those born with congenital heart
disease is lower than of the general population.7 For many
congenital cardiac lesions, the generation of patients cur-
rently reaching adulthood represents the first sizeable group
to have done so, and the late problems associated with
surgically treated congenital heart disease are becoming in-
creasingly apparent. Reports published to date have gener-
ally focused on individual lesions or on one aspect of caring
for adults with CHD, and the majority report single institu-
tion experiences.8-10 Of multi-institutional reports, many
rely on administrative data.11 There are a paucity of reliable
data available for use in counseling patients, families, and
other clinicians with respect to mortality and expected com-
plications for adults with CHD undergoing cardiac surgery.
The Society of Thoracic Surgeons (STS) Congenital Heart
Surgery Database collects perioperative information on all
patients at participating institutions undergoing operationsgery c November 2011
Abbreviations and Acronyms
ASD ¼ atrial septal defect
CHD ¼ congenital heart disease
CPB ¼ cardiopulmonary bypass
IQR ¼ interquartile range
STS ¼ Society of Thoracic Surgeons
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Dfor congenital heart disease. Approximately three quarters
of all centers performing congenital heart surgery submit
data to this database, and therefore it is a potentially valu-
able repository of surgical information on adults with
CHD.12 The primary objective of this study was to describe
the patient characteristics, most common operations, and
operative morbidity and mortality of patients aged 18 years
or more undergoing surgery for congenital heart disease, by
using the STS Congenital Heart Surgery Database. Informa-
tion concerning patients undergoing surgery for congenital
heart disease that is collected in the STS Adult Cardiac Sur-
gery Database is considerably less detailed than that col-
lected in the STS Congenital Heart Surgery Database.
Nonetheless, we also sought to determine the overall num-
ber of CHD operations that have been entered in the adult
database during the same period of time to permit consider-
ation of the primary dataset within a broader context.
MATERIALS AND METHODS
Data Source
The STS Congenital Heart Surgery Database contains operative, perio-
perative, and outcomes data on more than 180,000 patients undergoing
congenital heart surgery since 1998. Data on all patients undergoing con-
genital heart surgery at participating centers are entered into the database.
Data quality and reliability are ensured through intrinsic verification of data
and a formal process of site visits and data audits.13
In addition, we identified congenital procedures entered into the STS
Adult Cardiac Surgery Database. Although the adult database currently
captures more limited data regarding congenital heart operations, this in-
formation provides an estimate of the number of CHD operations per-
formed at adult hospitals or by adult cardiac surgeons.
The Duke Clinical Research Institute serves as the data warehouse and
analytic center for all of the STS National Databases. This analysis was ap-
proved by the Duke Institutional Review Board and by the STS Access and
Publications Committee.
Patient Population
Analysis of data from the STS Congenital Heart Surgery Database was
restricted to 68 centerswithmore than 85% complete data for all study vari-
ables. Although the STS Database contains nearly complete data for the
standard core data fields required to calculate in-hospital mortality, not all
centers submit complete data for all variables, such as patient preoperative
characteristics or postoperative complications. Therefore, it is standard
practice to exclude centers with more than 15%missing data for key study
variables tomaximize data integrity andminimizemissing data.14 From the
included centers, patients aged 18 years or more who underwent any con-
genital heart operation between 2000 and 2009 were included.
Similar criteria were applied to the STS Adult Cardiac Surgery Data-
base. The only congenital operations captured in the adult database duringThe Journal of Thoracic and Carthis time period included ASD repair, pulmonary valve replacement, and
‘‘congenital defect repair.’’
Data Collection
Data collected from the STS Congenital Heart Surgery Database in-
cluded demographic information, cardiac diagnoses, presence of noncar-
diac/genetic abnormality, and presence of any other preoperative factors
as defined in the database, includingmechanical circulatory support, acido-
sis, shock, arrhythmia, atrioventricular block, pulmonary hypertension,
mechanical ventilatory support, tracheostomy, renal failure (creatinine>
2), renal failure requiring dialysis, bleeding disorder, endocarditis, sepsis,
neurologic deficit, or seizure.15 Operative data included the surgical proce-
dure performed, whichwas analyzed individually and categorized using the
STS–European Association for Cardiothoracic Surgery risk stratification
system (category 1 ¼ lowest mortality risk, category 5 ¼ highest mortality
risk).16 This system was recently developed on the basis of empiric data
from approximately 80,000 patients, and it includes a greater number of op-
erations compared with other risk stratification systems.16 The number of
prior cardiothoracic operations was also collected, as well as cardiopulmo-
nary bypass (CPB) times. Outcomes data included in-hospital mortality, to-
tal postoperative length of stay, and postoperative complications, including
cardiovascular, pulmonary, neurologic, renal, infectious, and hematologic
complications, as well as the need for unplanned surgical reintervention
during the hospitalization, as defined in the STS Database.15
Data collection from the STS Adult Cardiac Surgery Database was lim-
ited to the procedure performed (as captured in this database), demograph-
ics, and in-hospital mortality. Procedures in the adult database were
categorized as isolated procedures or concomitant procedures in associa-
tion with coronary artery bypass grafting, aortic valve procedure, or mitral
valve procedure.
Analysis
Study variables were described using standard summary statistics. Pre-
operative, operative, and outcomes data were described for the overall co-
hort and for subgroups of patients undergoing the most common
operations. Because of the descriptive nature of the analysis, formal statis-
tical comparisons were not made. All analyses were performed using SAS
version 9.2 (SAS Institute Inc, Cary, NC).RESULTS
Society of Thoracic Surgeons Congenital Heart
Surgery Database
Patient characteristics and overall outcomes. A total of
5265 patients from 68 centers submitting data to the STS
Congenital Heart Surgery Database were included in the
primary analysis. Patient characteristics are shown in
Table 1. Patients’ median age was 25 years (interquartile
range [IQR], 20–35). The most common preoperative risk
factors were the presence of any noncardiac/genetic abnor-
mality (17%) and preoperative arrhythmia (14%). The
most common categories of operations were right ventricu-
lar outflow tract/pulmonary artery procedure (21% of all
operations, including pulmonary valve replacement or re-
pair, conduit operation, and pulmonary artery reconstruc-
tion), pacemaker/arrhythmia procedure (20%, including
pacemaker or defibrillator implantation/procedure, and
atrial or ventricular arrhythmia surgery), left ventricular
outflow tract/aortic valve procedure (18%, including sub-
aortic stenosis repair, aortic valve replacement or repair,diovascular Surgery c Volume 142, Number 5 1091
TABLE 1. Study population characteristics
Overall
(n ¼ 5265)
Pulmonary
valve
replacement
(n ¼ 574)
ASD repair
(n ¼ 365)
Conduit
operation
(n ¼ 328)
Aortic
aneurysm
repair
(n ¼ 136)
Mitral
valvuloplasty
(n ¼ 135)
Ross
operation
(n ¼ 108)
Fontan
revision/
conversion
(n ¼ 105)
Age (y) 25 [20–35] 25 [20–35] 33 [23–46] 23 [20–29] 24 [21–31] 26 [20–37] 22 [19–28] 27 [22–33]
Weight (kg) 69 [58–83] 70 [59–86] 71 [59–84] 67 [55–79] 78 [62–89] 66 [53–76] 73 [63–83] 68 [56–79]
Race, white 3872 (74%) 439 (76%) 242 (66%) 262 (80%) 112 (82%) 96 (71%) 91 (84%) 84 (80%)
Sex, male 2631 (50%) 277 (48%) 131 (36%) 178 (54%) 90 (66%) 38 (28%) 75 (69%) 51 (49%)
Noncardiac abnormality 899 (17%) 84 (15%) 25 (6.9%) 52 (16%) 32 (24%) 37 (27%) 7 (6.5%) 11 (10%)
Preoperative factors
Any 1655 (31%) 106 (18%) 63 (17%) 92 (28%) 25 (18%) 42 (31%) 15 (14%) 71 (68%)
Arrhythmia 735 (14%) 36 (6.3%) 20 (5.5%) 25 (7.6%) 4 (2.9%) 16 (12%) 1 (0.9%) 56 (53%)
AV block 144 (2.7%) 1 (0.2%) 1 (0.3%) 5 (1.5%) 1 (0.7%) 2 (1.5%) 1 (0.9%) 1 (1.0%)
Mechanical ventilation 89 (1.7%) 1 (0.2%) 0 (0%) 3 (0.9%) 2 (1.5%) 1 (0.7%) 0 (0%) 0 (0%)
Pulmonary hypertension 65 (1.2%) 3 (0.5%) 4 (1.1%) 6 (1.8%) 0 (0%) 3 (2.2%) 0 (0%) 1 (1.0%)
Neurologic deficit 177 (3.4%) 12 (2.1%) 8 (2.2%) 13 (4.0%) 3 (2.2%) 4 (3.0%) 3 (2.8%) 3 (2.9%)
Seizure 61 (1.2%) 6 (1.1%) 1 (0.3%) 6 (1.8%) 3 (2.2%) 2 (1.5%) 0 (0%) 0 (0%)
Endocarditis 73 (1.4%) 0 (0%) 1 (0.3%) 9 (2.7%) 4 (2.9%) 4 (3.0%) 3 (2.8%) 0 (0%)
Bleeding disorder 68 (1.3%) 8 (1.4%) 3 (0.8%) 8 (2.4%) 2 (1.5%) 2 (1.5%) 4 (3.7%) 3 (2.9%)
Continuous variables are presented as median [IQR]. Preoperative factors occurring in more than 1% of the overall study population are shown. ASD, Atrial septal defect;
AV, atrioventricular.
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Daortic root replacement of any type, aortic aneurysm repair,
Ross procedure, and Ross-Konno procedure), ASD closure
(7%), mitral valve repair or replacement (5%), and Fontan
operation (4%, any type). In-hospital mortality for the over-
all cohort was 2.1%, 27% had 1 or more postoperative
complications, and median postoperative length of stay
was 5 days (IQR 3–7).
Patient characteristics and outcomes associated with the
most common adult congenital heart disease operations.
All individual operations involving CPBwithmore than 100
patients were evaluated further; this included pulmonary
valve replacement, ASD repair, right ventricle to
pulmonary artery conduit operation, aortic aneurysm
repair, mitral valvuloplasty, Ross operation, and Fontan
revision/conversion. Tables 1 to 3 list the population
characteristics, operative characteristics, and outcomes forTABLE 2. Operative characteristics
Overall
(n ¼ 5265)
Pulmonary
valve replacement
(n ¼ 574)
ASD
repair
(n ¼ 365)
C
op
(n
STS–EACTS category
1 2051 (39%) –– ––
2 1793 (34%)
3 396 (7.5%)
4 675 (13%)
5 6 (0.1%)
No. of prior cardiothoracic
operations
1 [0–2] 1 [1–2] 0 [0–0] 2
CPB time (min) 117 [78–175] 91 [66–121] 61 [43–87]109
Continuous variables are presented as median [IQR]. ASD, Atrial septal defect; STS, Socie
1092 The Journal of Thoracic and Cardiovascular Surthese 7 operations. Pulmonary valve replacement was the
most common operation. In-hospital mortality for this oper-
ation was low (0.7%), and median length of stay was 5 days
(IQR, 4–6). Patients with ASD were relatively old at the
time of operation compared with patients undergoing other
operations (median, 33 years; IQR, 23–46). As expected,
they had a short CPB time (median, 61 minutes; IQR,
43–87). Patients with ASDhad amortality of 0% and a short
length of stay (median, 4 days; IQR, 3–5). The conduit op-
eration cohort was notable for having a rate of preoperative
neurologic deficit of 4.0%. In addition, this group had a high
number of previous cardiothoracic operations (median, 2;
IQR, 1–3). The conduit operation cohort also had a relatively
high rate of postoperative pulmonary complications (pleural
effusion, reintubation, andmechanical ventilation>7 days).
The aortic aneurysm repair subgroup was notable for havingonduit
eration
¼ 328)
Aortic
aneurysm
repair (n ¼ 136)
Mitral
valvuloplasty
(n ¼ 135)
Ross
operation
(n ¼ 108)
Fontan revision/
conversion
(n ¼ 105)
–– –– –– –– ––
[1–3] 1 [0–2] 0 [0–1] 0 [0–1] 2 [2–3]
[75–165] 172 [120–222] 120 [92–177] 195 [164–237] 195 [153–250]
ty of Thoracic Surgeons; EACTS, European Association for Cardiothoracic Surgery.
gery c November 2011
TABLE 3. Outcomes
Overall
(n ¼ 5265)
Pulmonary
valve
replacement
(n ¼ 574)
ASD
repair
(n ¼ 365)
Conduit
operation
(n ¼ 328)
Aortic
aneurysm
repair
(n ¼ 136)
Mitral
valvuloplasty
(n ¼ 135)
Ross
operation
(n ¼ 108)
Fontan
revision/
conversion
(n ¼ 105)
In-hospital mortality 109 (2.1%) 4 (0.7%) 0 (0%) 8 (2.4%) 3 (2.2%) 1 (0.7%) 2 (1.9%) 11 (11%)
Length of stay (d) 5 [3–7] 5 [4–6] 4 [3–5] 5 [4–7] 6 [4–8] 5 [4–8] 5 [4–6] 10 [7–13]
Postoperative complication
Any 1446 (28%) 135 (24%) 72 (20%) 96 (29%) 35 (26%) 48 (36%) 43 (40%) 54 (51%)
Arrhythmia 496 (9.4%) 39 (6.8%) 28 (7.7%) 26 (7.9%) 8 (5.9%) 22 (16%) 11 (10%) 24 (23%)
Low cardiac output 87 (1.7%) 4 (0.7%) 3 (0.8%) 5 (1.5%) 2 (1.5%) 4 (3.0%) 4 (3.7%) 9 (8.6%)
AV block requiring
permanent pacer
69 (1.3%) 0 (0%) 0 (0%) 1 (0.3%) 3 (2.2%) 1 (0.7%) 2 (1.9%) 1 (1.0%)
Cardiac arrest 52 (1.0%) 2 (0.4%) 0 (0%) 7 (2.1%) 3 (2.2%) 1 (0.7%) 0 (0%) 3 (2.9%)
Pleural effusion 162 (3.1%) 6 (1.1%) 6 (1.6%) 12 (3.7%) 4 (2.9%) 11 (8.2%) 4 (3.7%) 7 (6.7%)
Pneumonia 124 (2.4%) 19 (3.3%) 12 (3.3%) 3 (0.9%) 0 (0%) 0 (0%) 0 (0%) 1 (1.0%)
Reintubation 71 (1.4%) 1 (0.2%) 1 (0.3%) 8 (2.4%) 1 (0.7%) 2 (1.5%) 1 (0.9%) 6 (5.7%)
Mechanical ventilation>7 d 52 (1.0%) 0 (0%) 2 (0.6%) 7 (2.1%) 1 (0.7%) 0 (0%) 0 (0%) 6 (5.7%)
Unplanned reoperation 111 (2.1%) 4 (0.7%) 2 (0.6%) 6 (1.8%) 4 (2.9%) 3 (2.2%) 1 (0.9%) 5 (4.8%)
Bleeding requiring
reoperation
100 (1.9%) 7 (1.2%) 2 (0.6%) 6 (1.8%) 4 (2.9%) 1 (0.7%) 9 (8.3%) 4 (3.8%)
Renal failure requiring
temporary dialysis
56 (1.1%) 3 (0.5%) 0 (0%) 4 (1.2%) 0 (0%) 0 (0%) 0 (0%) 9 (8.6%)
Continuous variables are presented as median [IQR]. Postoperative complications occurring in more than 1.0% of the study population are shown. ASD, Atrial septal defect;
AV, atrioventricular.
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overall) and the highest risk of postoperative heart block re-
quiring a permanent pacemaker (2.2% vs 1.3% overall).
The patients undergoing mitral valvuloplasty were pre-
dominately female (72%) and had a high rate of noncar-
diac/genetic abnormality (27% vs 17% overall). These
patients also had a high risk of postoperative arrhythmia
(16% vs 9.4% overall) and a high rate of postoperative
pleural effusion (8.2% vs 3.1% overall). The Ross oper-
ation subgroup was relatively young (median, 22 years;
IQR, 19–28) and had a low rate of noncardiac/genetic
abnormality (6.5% vs 17% overall) and other preopera-
tive risk factors (14% vs 31% overall). The Ross sub-
group also had a long CPB time and a high rate of
bleeding requiring reoperation (8.3% vs 1.9% overall).
The Fontan revision/conversion cohort was notable for
a high rate of any preoperative risk factor, long CPB
times, high in-hospital mortality (11% vs 2.1% overall),
relatively longer postoperative length of stay (median,
10 days; IQR, 7–13), and frequent postoperative compli-
cations (51%).Society of Thoracic Surgeons Adult Cardiac Surgery
Database
Review of the STS Adult Cardiac Surgery Database re-
vealed 39,872 patients who had undergone ASD repair, pul-
monary valve replacement, or other ‘‘congenital defect
repair’’ either in isolation or along with coronary artery by-
pass grafting, aortic valve procedure, or mitral valveThe Journal of Thoracic and Carprocedure. (During the period 2000–2009, cases coded as
‘‘congenital defect repair’’ were not classified with any fur-
ther granularity in the STS Adult Cardiac Surgery Data-
base.) Table 4 displays the patient characteristics and
outcomes associated with these procedures.DISCUSSION
This report based on data in the STS Database analyzes
the operative outcomes of the growing population of adults
with congenital heart disease. The relatively young median
age for adults undergoing surgery for congenital heart dis-
ease is not surprising. Many operations performed in child-
hood are palliative and not expected to last a lifetime. Part of
the increase in the numbers of young adults with congenital
heart disease is accounted for by the fact that survival be-
yond the first decade or 2 of life is a new phenomenon for
some relatively common anomalies, such as hypoplastic
left heart syndrome.5 However, it should be noted that the
patients in our primary analysis included only those entered
into the STS Congenital Heart Surgery Database; thus, these
data are likely skewed toward younger patients undergoing
surgery at congenital heart surgery centers performed by
congenital heart surgeons. It has been shown that many
adults with CHD undergo surgery at adult centers.17 These
findings are confirmed in the present analysis in which
manymoreCHDoperationswere entered into the STSAdult
Cardiac Database versus the Congenital Heart Surgery Da-
tabase. Patients in the adult database were substantially
older compared with patients in the congenital database.diovascular Surgery c Volume 142, Number 5 1093
TABLE 4. Society of Thoracic Surgeons Adult Cardiac Surgery Database
ASD repair (n ¼ 26,117)
Congenital defect repair
(n ¼ 10,133)
Pulmonary valve
replacement (n ¼ 3622)
Isolated procedure 9602 (37%) 2835 (28%) 1738 (48%)
Age (y) 48 [36–59] 44 [32–58] 38 [28–49]
In-hospital mortality 2.1% 3.7% 2.8%
Concomitant procedure* 16,515 (63%) 7298 (72%) 1884 (52%)
Age (y) 66 [56–75] 65 [54–74] 47 [37–56]
In-hospital mortality 5.0% 4.5% 3.5%
Continuous variables are presented as median [IQR]. *Concomitant procedure¼ procedure performed in association with coronary artery bypass grafting, aortic valve procedure,
or mitral valve procedure. ASD, Atrial septal defect.
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STS Congenital Heart Surgery Database and range of
2.1% to 5.0% mortality in the STS Adult Cardiac Surgery
Database are within the range of previously published
figures of 1.9% to 4.8% derived from the Nationwide Inpa-
tient Sample,11 an administrative database. Despite 31% of
our overall cohort having at least 1 preoperative risk factor
and 28% experiencing at least 1 postoperative complica-
tion, mortality was generally low and length of stay was rel-
atively short in the subgroups analyzed. The length of stay
in our study is comparable to the 8 to 10 days described in
a previous report from an administrative database.11 As this
population continues to grow in number over the coming
years, with an expected increase in the fraction of patients
with complex disease having benefited from newer and
more efficacious treatment strategies, continued clinical
vigilance will be required to maintain or improve this level
of morbidity and mortality.
The highest mortality in our subgroup analysis was found
in those undergoing Fontan revision/conversion. Primary
Fontan operation early in childhood is associated with low
rates of operative mortality, with previous single institution
series reporting 1% to 2% mortality.18,19 The late
morbidities associated with the Fontan circulation are
now being increasingly recognized. The Pediatric Heart
Network Fontan study reported stroke/thrombosis in 8%,
seizures in 3%, and protein-losing enteropathy in 4% of pa-
tients undergoing the Fontan procedure approximately
8 years after the procedure.20 It is not surprising that pa-
tients with declining status who are referred as adults for re-
vision or conversion of the Fontan circulation have
numerous comorbidities and are a high-risk surgical group.
In the present analysis, we found that Fontan revision/con-
version is associated with a mortality rate of 11%. This is
higher than that reported by Mavroudis and colleagues21
in the largest single institution series published to date.21
Differences in the patient populations could account for
the differences in mortality between that study and our anal-
ysis. Our Fontan revision/conversion cohort had a median
age of 27 years, whereas the study by Mavroudis and col-
leagues analyzed cohorts in 3 eras, with median ages of
16, 19, and 24 years. Our cohort also had noncardiac/1094 The Journal of Thoracic and Cardiovascular Surgenetic abnormality in 10%, neurologic deficit in 3%,
and bleeding disorder in 3% of patients.
The subgroups undergoing pulmonary valve replacement
and ASD repair had few preoperative risk factors and low
morbidity and mortality. The mortality for pulmonary valve
replacement was lower than that reported in a study from
Norway,which included 79 patients agedmore than 17 years
receiving a pulmonary valve replacement, with overall early
mortality of 2.7%.22 Shinkawa and colleagues23 analyzed
73 patients undergoing pulmonary valve replacement and
reported zero perioperative deaths.23 Mortality for ASD
repair was zero in our study and has been reported to be
0% to 1.2%.24,25 This is an important observation that
should be considered in evaluation of innovative
nonsurgical means of accomplishing ASD closure.
The conduit reoperation subgroup was notable for having
a high rate of preoperative neurologic deficit (4.0%). The
cause of this cannot be ascertained from the data available
in this study. Our speculation to explain this finding in-
cludes a history of undergoingmultiple cardiothoracic oper-
ations and exposure to multiple episodes of CPB. The
mortality for aortic aneurysm repair in this study (2.2%)
is similar to that in a single institution study from the adult
cardiac literature (2.6%).26 Mitral valvuloplasty carried
a lower mortality (0.7%) than that reported in an Australian
congenital study (4%).27 However, this single institution
Australian study included younger patients (aged 3 days
to 21 years), and all 3 mortalities were in patients aged
less than 8 years. The Ross operation subgroup had the
same mortality (1.9%) as a 14-year, single institution study
of 160 patients.28 The high rate of bleeding requiring reop-
eration (8.3%) in patients undergoing the Ross operation
might be explained by the long cardiopulmonary time and
the nature of the operation, which includes many suture
lines in the high-pressure left ventricular outflow tract.
The results from the STS Adult Cardiac Surgery Data-
base must be interpreted with caution. The category ‘‘con-
genital defect repair’’ potentially represents a myriad of
procedures of varying complexity. There are currently lim-
ited data collected regarding the diagnoses, patient charac-
teristics, and details of the procedures performed in the
adult database such that detailed analyses are not possible.gery c November 2011
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of congenital heart surgery operations in the Adult Cardiac
Surgery Database, which for the 10-year period represented
by these data approaches 40,000 cases. Important modifica-
tions to both the STS Congenital Heart Surgery Database,
which went into effect in 2010, and the STS Adult Cardiac
Surgery Database, which went into effect in 2011, will
make more detailed analyses of the entire cohort of adults
with CHD undergoing surgery from either database
possible. Starting in 2010, the STS Congenital Heart
Surgery Database began to collect, on all patients aged 18
years or more, the complete list of patient factors that are
pertinent to adult patients; these factors were previously
collected only in the STS Adult Cardiac Surgery Database.
Starting in 2011, the complete list of congenital cardiac
diagnoses and procedures is now shared by both the STS
Congenital Heart Surgery Database and the STS Adult
Cardiac Surgery Database.
Limitations
The limitations of this study are primarily related to the
nature of the STS Database. Not all US centers participate
in the STS Database or submit complete data. Thus, the re-
sults of this study may not be generalizable to adults with
CHD undergoing surgery at all US centers. In addition, as
noted above, our primary analysis focused on patients en-
tered into the STS Congenital Heart Surgery Database.
We found there are many more congenital operations cap-
tured in the STS Adult Cardiac Surgery Database. As dis-
cussed, modifications to the adult database will facilitate
future detailed analyses of all CHD operations in adults
regardless of which database they are entered into. Finally,
the present analysis was primarily descriptive in nature. De-
tailed information regarding patient preoperative hemody-
namic status and other clinical information, in addition to
center-level data regarding the presence of a dedicated adult
congenital program and surgeon experience with adult con-
genital procedures, is not currently captured in the database;
thus, we were not able to include these factors in the analy-
sis or describe their relationship with outcome.
CONCLUSIONS
This analysis of adults with CHD in the STS Congenital
Heart Surgery Database offers a focused view of this emerg-
ing population. The majority of patients undergo surgery in
the third and fourth decades of life, and in-hospital mortal-
ity is low for most types of procedures. The mortality rate
associated with Fontan revision/conversion is higher, which
is likely related to important comorbidities that occur in the
setting of declining function of the Fontan circulation. For
the entire cohort studied, postoperative complications
were common, justifying further efforts to characterize
and understand risk factors in the adult populations with
congenital cardiac disease and processes of care that mayThe Journal of Thoracic and Carreduce overall morbidity. Recent enhancements of the
STS Databases should result in the availability of more
complete and representative datasets for future analyses.
Initiatives to foster collaboration of STS Adult Cardiac
and Congenital Heart Surgery Databases with longitudinal
registries of adults with CHDmay provide the best opportu-
nity to evaluate long-term outcomes in this patient
population.29References
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Dr Joseph Dearani (Rochester, Md). I have no disclosures. The
authorship has provided a well-written article and presentation of
a descriptive review of a large number of adult patients with CHD
who underwent selected procedures at many institutions. Limita-
tions of this review were acknowledged, and this study exemplifies
the strengths and weaknesses of a retrospective review from the
STS database.
Strengths include a large patient cohort of more than 5000
adults with CHD, a growing subspecialty with few data present
in the literature. Most of the data in this review were from the
STS congenital database, and additional data on 3 adult CHD pro-
cedures, 2 common ones being pulmonary valve replacement and
ASD closure, are from the adult STS database. The assumption is
that the majority of procedures in the congenital database were
performed by congenital surgeons; however, it is not clear who
were the primary operators in the adult database, but it is likely
that most were adult surgeons.
The overall early mortality was low at 2%, and not surprisingly
it was highest in the single ventricle group at 11%. These findings
are consistent with other data in the literature. Postoperative mor-
bidity was common, occurring in approximately one third of the
entire group of adults with CHD as you have outlined.
A few findings deserve comment. The early mortality was 2%
for the conduit replacement group, one of the most common pro-
cedures performed in CHD, which is higher than many reports in1096 The Journal of Thoracic and Cardiovascular Surthe literature. This may be because the procedure was not an iso-
lated conduit replacement, was related to the underlying congeni-
tal diagnosis, or in the presence of multiple prior sternotomies. In
the conduit group, 4% had had a stroke preoperatively, which may
have been due to the greater number of prior operations or preex-
isting cyanosis related to palliation before complete repair in the
earlier days of cardiac surgery. The 30% complication rate is
high, particularly with regard to respiratory complications. Con-
duit replacement is generally viewed as a relatively low-risk,
straightforward procedure even in the face of multiple prior oper-
ations. Here it stands out as a procedure with significant morbidity
and the highest early mortality for all of your groups excluding the
Fontan group.
The finding of no early mortality in ASD closure in the congen-
ital database is excellent and sets the gold standard for newer, less-
invasive techniques. However, the ASD repair mortality of 2% to
5% in the adult database, depending on whether it was performed
in isolation or with other procedures, stands out as high. This may
be due in part to improper patient selection or adult surgeons per-
forming congenital operations. The adult STS database also dem-
onstrated a high early mortality of 3.5% for pulmonary valve
replacement. This point deserves emphasis that adult surgeons
should not be performing congenital procedures even if it is a ‘‘sim-
ple ASD closure or pulmonary valve replacement.’’
I commend you and your coauthors for your efforts to examine
a large amount of data and learn more about this difficult and grow-
ing patient population, but it is disappointing there is not a single
statistical analysis with a P value that was performed with 30+ var-
iables in 5000+ patients. This highlights one of the weaknesses of
the STS database, namely, that it is descriptive with some findings
requiring clarification that will go largely unanswered.
I have 3 questions for you.
First, can you clarify why the risk of heart block was highest in
the group of patients undergoing ascending aortic surgery?
Second, can you explain the nature of the arrhythmias and the
arrhythmia procedures that were performed?
Third, what do you think is the most important new finding from
your review that will add to the current literature?
Dr Mascio. To address your first question about heart block in
ascending aortic surgery, I really don’t have a good explanation for
that. It’s one of theweaknesses of the database.We know that a cer-
tain number of ascending aortic aneurysms were done and that
a certain percentage had heart block. Beyond that it’s hard to
know the specifics of individual cases.
The situation is the same for the arrhythmias. There is simply
a box to check whether there is a preoperative arrhythmia or post-
operative arrhythmia. On the basis of the data we collected for this
study, I cannot comment on the type of arrhythmia or if an inter-
vention, surgical or medical, was done.
As far as the most important new finding, I was impressed with
the number of congenital cases done at adult hospitals. I think this
puts an exclamation point on something we all know—that these
patients are trying to find their home. In other words, some seek
care at congenital hospitals. There seems to be no standard formula
for their care yet. Although the STS database is not perfect, it does
provide a snapshot of what’s really going on everywhere.
Dr Rodolfo Neirotti (Cambridge, Mass). I think this is a large
and increasing number of patients who deserve some additionalgery c November 2011
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Dconsiderations. One of them is to try to find and adopt a system of
risk stratification for them. There is a recent article from Rotter-
dam in The Netherlands showing that the current pediatric score
methods are not helpful unless age is added to the formula.
Are you considering or have you used some sort of risk stratifi-
cation score? It could be important to determinewho these patients
are and where they should undergo surgery, particularly those with
higher risk.
This group of patients requires a different business model, a dif-
ferent pathway, and a different mindset. And that is applying to
them the available knowledge on children’s heart diseases in addi-
tion to the mindset of adult care. Do you have some inference and
recommendations regarding this potential business model, path-
way, and mindset for this particular group of patients?
Dr Mascio. To address your first question, I think the next step
should be to start looking at risk stratification. Now that we have an
idea of how many adult patients have complications and what the
overall survival is, it is time to see if we can link pre- or postoper-
ative factors to mortality.
To address your second question as far as business model and
mindset, I would say that complex patients with adult CHD belong
in children’s hospitals or hospitals that take CHD cases. There
have been publications that have indicated a lower in-hospital mor-The Journal of Thoracic and Cartality rate for adults with CHDwhen they undergo operation by pe-
diatric heart surgeons and they’re cared for in CHD centers. That’s
mymindset, and I think that’s what the business model needs to be.
Admitting a Fontan case to a unit that takes care of coronary by-
pass graft cases is not a good plan.
Dr Tara Karamlou (Seattle, Wash). I just wanted to make one
point and then ask one question. I applaud your use of this new
database, because our group has reached similar conclusions us-
ing the Nationwide Inpatient Sample. However, just to empha-
size, I think this current data set is probably not, at least right
now and maybe not for many years, a good one to look at this
population, because from our own literature most of these pa-
tients aren’t cared for in tertiary care settings. I would hypothe-
size that the participants of the congenital database in particular
are probably not the centers where most of these patients are re-
ceiving care.
You alluded to and it’s probably a surrogate for whether it’s a pe-
diatric heart surgeon or an adult-acquired surgeon doing the cases.
Is there a way or do you plan to look at surgeon factors? Because I
think that would be a good use of this data set.
Dr Mascio. We were not able to sort out what type of surgeon
performed the operation and at what type of hospital, but it should
be a part of future studies using the database.diovascular Surgery c Volume 142, Number 5 1097
